as identified from our prospectively collated institutional approved database. Pre-, intra-and postoperative characteristics, oncological outcomes, 90-day complications, recurrence free survival (RFS) and cost variables (adjusted to 2017 USD) were compared on univariate analysis. RFS was calculated by log-rank test and multivariable regression was used to assess the effect of ERAS on significant outcomes identified on univariate analysis.
erectile dysfunction (ED) after prostate cancer treatment. Previous work has suggested that placement of the Adrianne mini-jupette graft with inflatable penile prosthesis can significantly improve these bothersome symptoms. Here, we sought to describe our modified technique for placement of a "mini male sling" (MMS) at the time of penile prosthesis (PP) placement for men with ED and climacturia with or without mild SUI and assess early postoperative outcomes from two centers.
METHODS: A retrospective review was performed for patient who underwent IPP and MMS placement with Virtue sling mesh or Tutoplast human pericardium (Coloplast Corp, Minneapolis, MN) by two high-volume prosthetic surgeon between 2016-2018 using a similar technique. After proximal exposure, the MMS is sutured to the corpora at the level of the bulbar urethra, proximal to the planned corporotomies. Care is taken to avoid excessive tension on the urethra. Changes in patient-reported climacturia and pads per day (PPD) for SUI assessed pre-operatively and at each post-operative visit were compared for each patient using McNemar's test with a statistical significance threshold of p<0.05.
RESULTS: Thirty-four men underwent both IPP and MMS placement (30 concurrent IPP/MSS, 4 sequential IPP/MSS). Mean patient age was 68 years (SD 6.5) and mean patient BMI was 26 (SD 3.4). Etiology for ED and urinary symptoms was prostatectomy (RP) 28/ 34 (82%) and RP plus radiation in 6/34 (18%). Virtue mesh MMS was used in 29/34 (85%), and Tutoplast in 5/34 (15%). Preoperative urinary symptoms included climacturia-only in 10/34 (29%), SUI only in 6/34 (18%), and combined climacturia/SUI in 18/34 (53%). For those with SUI, mean preoperative PPD was 1.5 (SD 1.1; range 0.5 -4). At a mean follow-up was 3.8 months (SD 2.8), climacturia resolved in 28/ 28 patients (100%). Mean postoperative pad use was 0.4 PPD (SD 0.7) and mean ppd decrease was 1.0 (SD 0.8; p<.001). Complete SUI resolution was seen in 15/24 (63%), with improvement noted in an additional 6/21 (29%). No difference in outcomes was seen based on surgeon or sling-type. Complications included penile edema in 2 patients (6%) and transient postoperative urinary retention in 1 patient (3%).
CONCLUSIONS: Our early results suggest that placement of an IPP with MMS for ED and climacturia or SUI via our modified approach significantly improves urinary symptoms. While further study is needed, this approach may be considered in the appropriately counseled patient.
Source of Funding: none

MP27-02 GLANS HYPERMOBILITY ASSOCIATED WITH PLACEMENT OF A PENILE PROSTHESIS: INCIDENCE AND TREATMENT OPTIONS
Alfredo Suarez-Sarmiento* Jr., Matthew Brennan, Edward Gheiller, Alfredo Suarez-Sarmiento, Paul Perito, Coral Gables, FL INTRODUCTION AND OBJECTIVES: Hypermobile glans deformity has been considered a "complication" of penile prosthesis implantation (IPP) in which the glans penis does not mount on the anterior tip of the prosthesis. Previous literature has stated that this deformity usually results from the surgeon incorrectly sizing the prosthesis or inadequate distal dilation. We sought to evaluate our single institutional experience to determine the incidence of true hypermobility. Post-operative outcomes without intraoperative resolution of the deformity are evaluated.
METHODS: From April to October, 2018, patients undergoing penile prosthesis implantation were identified from our institutional database. All clinical notes, patient demographics, comorbidities and surgical outcomes were reviewed. Hypermobility was determined and agreed upon independently by all Board-Certified surgeons operating in our high-volume training program where we devised a scale which gauges the existence and character of the deformity. True hypermobile glans deformity was detected and evaluated intraoperatively and postoperatively. No patients underwent glanulopexy at the time of the procedure. Post-operative treatment options included: no treatment, PDE5 inhibitors, Trimix gels and Durosphere injection. Patients that failed all conservative approaches then underwent glanulopexy.
RESULTS: Of 232 patients undergoing IPP, 58 (25.1%) were determined to have true hypermobility by all surgeons present. Dorsal hypermobility was found more frequently in patients, compared to ventral (58.6% vs 17.2%) respectfully, while 24.2% had both dorsal and ventral hypermobility. 44 (75.6%) patients required no postoperative treatment and were satisfied with their outcome. Of those requiring treatment, 9 (15.5%) needed PDE5 inhibitors or Trimix gels for stability, while only 2 (3.7%) underwent Durosphere injections of the glans for support. Only 3 (5.2%) patients needed glanulopexy using an anchoring suture with or without penile shaft skin reduction.
CONCLUSIONS: Ensuring adequate distal dilation and correct penile prosthesis sizing is important and can be the determining factor regarding the development of a true SST deformity. However, true hypermobility of the glans penis is found in at least 25.1% of patients despite technique. This incidence is essential data to report to patients when counseling them preoperatively and setting proper expectations for IPP placement. Considering the low incidence of patients requiring glanulopexy, intraoperative glanulopexy at the time of IPP placement may not be advised.
Source of Funding: none
MP27-03 PENILE PROSTHESIS RESERVOIR REMOVAL: SURGICAL DESCRIPTION AND PATIENT OUTCOMES
Samuel Aly*, Newark, NJ; Jonathan Clavell, Run Wang, Houston, TX; Hossein Sadeghi-Nejad, Newark, NJ INTRODUCTION AND OBJECTIVES: Infection of a three-piece inflatable penile prosthesis (IPP) is a rare but serious complication which can be particularly challenging. When removing a 3-piece IPP for infection or malfunction, the cylinders and scrotal pump are easily accessible. However, removal of the reservoir component can be technically challenging because of its difficult locations either deep in the pelvis or high in the abdominal wall, particularly when attempting to remove all the components through a single incision. In this abstract, we describe our approach utilizing an open technique for safe removal of a reservoir located either in the space of Retzius (SOR) or an alternative/ectopic space through the original penoscrotal incision using a lighted retractor and precise dissection with Bovie electrocautery METHODS: We describe our preferred method for removal of prosthetic reservoir and present a retrospective review of patient outcomes after reservoir removal. Primary outcomes included immediate or late complications. Secondary outcomes included operative time.
RESULTS: Thirty-four patients underwent reservoir removal with the use of our described technique. Twenty-three patients (67.6%) had reservoirs removed secondary to device malfunction and 11 (32.4%) secondary to infection. A total of 18 reservoirs (52.9%) were found in the SOR while the other 16 (47.1%) were in an alternative/ ectopic space. Two cases (5.9%) required a counter-incision in order to remove the reservoir. Mean overall operative time was 96.2 mins (range 35e175). There were no complications in the current series. There was no statistical difference in operative time between reservoirs removed secondary to malfunction when compared to infection (p[0.283). However, there was a difference in operative time between reservoirs removed from the SOR when compared to those removed from an ectopic space, with mean OR times of 104.5 and 75.4 mins, respectively (p[0.001) .
CONCLUSIONS: Although removal of a reservoir deep in the SOR or placed in alternate/ectopic locations can be challenging, the use of a lighted retractor, meticulous dissection, and a few technical maneuvers described allow for safe removal of the reservoir completely intact while avoiding complications. Our technique for a secondary incision in particularly difficult cases is also described.
